• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

obesity drugs

money bag of money cash sack of money
Biotech

Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera

Amid the whiplash bidding war for obesity biotech Metsera, Novo Nordisk's CEO has, quite literally, told Pfizer to put its money where its mouth is.
Fraiser Kansteiner Nov 7, 2025 10:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Lilly links amylin drug to 20% weight loss, races to phase 3

Nov 6, 2025 8:20am
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024

FTC tells Novo that Metsera offer may violate US merger law

Nov 5, 2025 4:26pm
Make a delay and accumulation of outstanding tasks Full stop

Terns mothballs obesity program after phase 2 data fall short

Oct 22, 2025 7:15am
Measuring tape on top of cash

Kailera raises hefty $600M to take Zepbound rival into ph. 3

Oct 14, 2025 9:20am
weight loss drugs obesity

Skye's CB1 blocker fails to reduce weight in obesity study

Oct 6, 2025 7:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings